

| 货号 | HY255016 |
|---|---|
| 品牌 | abinScience |
| 描述 |
Caplacizumab (HY255016) is a research-grade recombinant antibody targeting von Willebrand antigen II. Produced in mammalian cells with native-like glycosylation.
Highlights
|
| 种属反应性 | Human |
| 应用 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| 宿主 | Human |
| 同种型 | VH-VH |
| 表达系统 | Mammalian cells |
| 克隆类型 | Monoclonal |
| 靶标 | von Willebrand antigen II, von Willebrand factor, F8VWF, vWF, VWF |
| 内毒素水平 | < 10 EU/mg |
| 纯度 | >95% purity as determined by SDS-PAGE. |
| 纯化方式 | Protein A/G purified from cell culture supernatant. |
| Accession号 | P04275 |
| 状态 | Liquid |
| 保存溶液 | 20 mM citric acid, 6.2% sucrose, 0.01% Tween80 Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
| 稳定性和存储 | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| 别名 | ALX-0081, PMP12A2h1-linkerAAA-PMP12A2h1, caplacizumab-yhdp, 915810-67-2 |
| 背景 | von Willebrand factor (VWF) is a ~309 kDa protein. Important in the maintenance of hemostasis, it promotes adhesion of platelets to the sites of vascular injury by forming a molecular bridge between sub-endothelial collagen matrix and platelet-surface receptor complex GPIb-IX-V. Also acts as a chaperone for coagulation factor VIII, delivering it to the site of injury, stabilizing its heterodimeric structure and protecting it from premature clearance from plasma. |
| Note | For research use only. Not suitable for clinical or therapeutic use. |

SDS-PAGE for Anti-Human Von Willebrand Factor Reference Antibody (Caplacizumab, RUO)



24小时产品查询

扫一扫关注我们

专属渠道经理